Long term recombinant interferon alpha treatment in MS with special emphasis to side effects.
Durelli L, Bongioanni MR, Ferrero B, Imperiale D, Verdun E, Oggero A, Gentile E, Bradac GB, Bergui M, Bergamini L, Bergamasco B.
Durelli L, et al. Among authors: bergamini l.
Mult Scler. 1996 Jul;1(6):366-71. doi: 10.1177/135245859600100617.
Mult Scler. 1996.
PMID: 9345419
Clinical Trial.